| Features: |
|
HDN-1 is a naturally occurring fungal
epipolythiodioxopiperazine / epipolythiopiperazine-2,5-dione
(ETP) isolated from the Antarctic fungus
Oidiodendron truncatum GW3-13. HDN-1 has demonstrated preclinical
anticancer activity and acts as a direct Hsp90 inhibitor,
binding the C-terminal region of Hsp90α. Hsp90 inhibition by HDN-1 promotes
degradation of multiple oncogenic client proteins, enhances downregulation of
wild-type and mutant EGFR and suppresses tumour-cell proliferation. HDN-1 has
also induced differentiation followed by apoptosis in selected promyelocytic
leukemia cell lines. Its mechanism overlaps with that of the structurally
related ETP chaetocin, which also inhibits Hsp90, but HDN-1 and chaetocin are
chemically distinct compounds and should be maintained as separate products.
HDN-1 should be classified as an experimental natural fungal metabolite
/ epipolythiodioxopiperazine / Hsp90 inhibitor, with current anticancer
evidence predominantly preclinical. |
| Source: |
| Type: |
| SUV39H1/KMT1A (suppressor of variegation 3-9 homolog 1; H3K9 histone methyltransferase) is a SET-domain lysine methyltransferase that catalyzes methylation of histone H3 lysine 9, particularly formation of H3K9me3, a repressive chromatin mark associated with heterochromatin and transcriptional silencing. SUV39H1 regulates chromatin organization, genome stability, cellular differentiation, senescence and gene expression. In several cancers, increased SUV39H1 activity can promote epigenetic silencing of tumour-suppressive genes, stemness, proliferation and treatment resistance, although its role can vary by tumour context. In such settings, the cancer-associated direction is commonly up and the desired anticancer modulation is down or methyltransferase inhibition. |
| 7169- | HDN-1, | CHA, | Identification of epipolythiodioxopiperazines HDN-1 and chaetocin as novel inhibitor of heat shock protein 90 |
| - | in-vitro, | Lung, | H1975 | - | in-vitro, | Lung, | HCC827 | - | in-vitro, | Lung, | A549 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:434 Target#:1592 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid